Researchers conducted a systematic review to understand how the NLRP3 inflammasome affects the body during sepsis. This protein complex acts as a central platform for how the immune system reacts to severe infection.
The review found that NLRP3 plays a critical dual role in the development of sepsis. It contributes to both pro-inflammatory effects, which increase inflammation, and immunosuppressive effects, which can lead to immune paralysis.
Because this protein helps drive both sides of immune dysregulation, scientists are looking at ways to target it. The goal of these potential strategies is to help restore a healthy balance to the immune system during a severe infection.
It is important to note that this is a review of existing research rather than a clinical trial on patients. While these findings highlight a potential target for future treatments, more research is needed to see if targeting this protein can safely help patients in a clinical setting.